The targeted radiotherapies for cancer market is experiencing significant growth, driven by advancements in technology and ...

Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

The Race for the Global Radiotherapy Cancer Market; Actinium Pharmaceuticals’ (ATNM) Big Bet To view an enhanced version of ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Lutetium Lu 177 vipivotide tetraxetan combined with ARPI and ADT improved rPFS in PSMA-positive mHSPC patients compared to ARPI and ADT alone. Lutetium Lu 177 vipivotide tetraxetan significantly ...

RECIST was developed in 2000 by the National Cancer Institute, European Organization for Research and Treatment of Cancer, and National Cancer Institute of Canada, with revision to RECIST 1.1 in 2009 ...

Screenings will be available at selected BIG and CARiNG Pharmacy outlets in the Klang Valley from 15 November 2025 to 11 ...

Scientists of Tomsk Polytechnic University together with their colleagues have developed a new radiopharmaceutical for effective diagnosis of prostate cancer, including at early stages. The first ...

President Donald Trump said he is 'on it' after 'Dilbert' creator Scott Adams asked for help with prostate cancer treatment.

Dr. Lee concluded his presentation discussing the comparative performance of UNFOLD AI, PSMA-PET, and mpMRI for prostate ...

Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, ...

"Dilbert" creator Scott Adams makes urgent plea to Trump for help getting cancer treatment after reported Kaiser Permanente ...